Gyre Therapeutics (GYRE) Other Working Capital Changes (2010 - 2026)
Gyre Therapeutics (GYRE) reported Other Working Capital Changes of $912000.0 for Q1 2026, down 83.54% year-over-year from $5.5 million in Q1 2025, and up 79.17% quarter-over-quarter from $509000.0 in Q4 2025.
Gyre Therapeutics (GYRE) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 17 years of Other Working Capital Changes data on file, last reported at $912000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $912000.0, down 83.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.4 million (down 209.48% YoY), and the FY2025 annual result was $10945.0, down 52.41% from the prior year.
- Other Working Capital Changes rose to $912000.0 in Q1 2026 per GYRE's latest filing, from $509000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $5.5 million in Q1 2025 and troughed at -$5.4 million in Q2 2025.
- A 5-year average of -$137531.2 and a median of $14729.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes surged 8216.17% in 2022, then sank 2802.15% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$743000.0 in 2022, then increased by 23.69% to -$567000.0 in 2023, then sank by 210.41% to -$1.8 million in 2024, then jumped by 128.92% to $509000.0 in 2025, then soared by 79.17% to $912000.0 in 2026.
- Business Quant data shows GYRE's Other Working Capital Changes at $912000.0 in Q1 2026, $509000.0 in Q4 2025, and -$398000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 912,000.00 |
| Mar 31, 2026 | 912,000.00 |
| Dec 31, 2025 | 509,000.00 |
| Dec 31, 2025 | 509,000.00 |
| Sep 30, 2025 | -398,000.00 |
| Sep 30, 2025 | -398,000.00 |
| Jun 30, 2025 | -5.45 Mn |
| Jun 30, 2025 | -5.45 Mn |
| Mar 31, 2025 | 5.54 Mn |
| Mar 31, 2025 | 5.54 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Dec 31, 2024 | -1.76 Mn |
| Sep 30, 2024 | -398,000.00 |
| Sep 30, 2024 | -398,000.00 |
| Jun 30, 2024 | 657,000.00 |
| Jun 30, 2024 | 657,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | -567,000.00 |
| Dec 31, 2023 | -567,000.00 |